Mereo BioPharma Group - Cash Flow Statement 2018-2024 | MREO

Fifteen years of historical annual cash flow statements for Mereo BioPharma Group - (MREO).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021202020192018
$-29.47$-42.22$19.58$-213.72$-52.50$-49.80
$0.57$0.18$0.88$2.05$2.01$0.05
$9.36$-4.43$-29.02$166$0.26$4.77
$9.93$-4.25$-28.13$168$2.28$4.82
$0$0$-0.81$0.18$-1.20$1.07
$0$0$0$0$0$0
$-1.26$0.62$-1.73$-4.56$-8.59$2.14
$-0.33$-2.97$0$0$0$0
$-1.59$-2.35$-2.54$-4.38$-9.79$3.21
$-21.13$-48.82$-7.20$-36.39$-58.65$-30.88
$0$-0.01$-0.74$-0.02$-0.03$-0.04
$-0.42$0$0.16$2.34$0$0
$0$0$0$-0.45$12.86$0
$0$0$0$0$41.97$0
$0$0$0$0$0$0
$0$0$0$0$41.97$0
$0$2.00$0.00$0.06$0.48$0.38
$-0.42$1.99$-0.58$1.92$55.28$0.34
$0$0$0$31.55$0$0
$-3.19$0$-0.95$-2.68$-2.82$0.61
$-3.19$0$-0.95$28.87$-2.82$0.61
$11.61$0$108$25.85$-1.27$-0.05
$11.61$0$108$25.85$-1.27$-0.05
$0$0$0$0$0$0
$-0.44$0.20$-0.32$-10.13$-3.19$-3.33
$7.97$0.20$107$44.60$-7.29$-2.77
$-10.76$-59.22$97.39$9.14$-11.10$-33.37
$4.92$4.77$4.54$2.00$2.09$2.92
$0$0$0$0$0$0